Edward P. Sloan
Department of Emergency Medicine
University of Illinois at Chicago
Illinois 60612
USA
Name/email consistency: high
- The use of the Revised Trauma Score as an entry criterion in traumatic hemorrhagic shock studies: data from the DCLHb clinical trials. Sloan, E.P., Koenigsberg, M., Clark, J.M., Desai, A. Prehosp. Disaster. Med (2012)
- Diaspirin cross-linked hemoglobin infusion did not influence base deficit and lactic acid levels in two clinical trials of traumatic hemorrhagic shock patient resuscitation. Sloan, E.P., Koenigsberg, M.D., Philbin, N.B., Gao, W. J. Trauma (2010)
- The lack of consistent diaspirin cross-linked hemoglobin infusion blood pressure effects in the US and EU traumatic hemorrhagic shock clinical trials. Sloan, E.P., Philbin, N.B., Koenigsberg, M.D., Gao, W. Shock (2010)
- Prehospital trauma research methodology. Sloan, E.P., Schlichting, A.B. Prehosp. Emerg. Care (2002)
- Post hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock. Sloan, E.P., Koenigsberg, M., Brunett, P.H., Bynoe, R.P., Morris, J.A., Tinkoff, G., Dalsey, W.C., Ochsner, M.G. J. Trauma (2002)
- Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. Sloan, E.P., Koenigsberg, M., Gens, D., Cipolle, M., Runge, J., Mallory, M.N., Rodman, G. JAMA (1999)
- The informed consent process and the use of the exception to informed consent in the clinical trial of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock. DCLHb Traumatic Hemorrhagic Shock study group. Sloan, E.P., Koenigsberg, M., Houghton, J., Gens, D., Cipolle, M., Runge, J., Mallory, M.N., Rodman, G. Acad. Emerg. Med (1999)
- A proposed consent process in studies that use an exception to informed consent. Sloan, E.P., Nagy, K., Barrett, J. Acad. Emerg. Med (1999)
